Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07695753 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Ability of Sunscreen Products to Modulate the Effects of Deep UVA +/- HEV Blue Light Induced Pigmentation and Biomarkers of Cutaneous Oxidative Stress
A NA study, sponsored by Kenvue Brands.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT07695753 is a NA study that has completed, run by Kenvue Brands. The registered enrollment target is 22 participants.
The verdict
NCT07695753, a NA study, has completed, sponsored by Kenvue Brands.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
To assess the level of sub pigmentation following an acute exposure to a Deep Ultraviolet A and high energy Blue Light wavelengths (380-420 nm). This study will compare the unprotected control with test products in Condition #1 and Condition #2 to assess pigmentation as well as cutaneous oxidative stress and inflammation biomarkers that occur with exposure to the same light regimen.
Interventions
- OTHER Sunscreen application #1
- OTHER Sunscreen application #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2025-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07695753
The ClinicalTrials.gov registry entry for NCT07695753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kenvue Brands, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sunscreen application #1 is the first listed.
NCT07695753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07695753 about?
NCT07695753 is a clinical study titled "A Study to Evaluate the Ability of Sunscreen Products to Modulate the Effects of Deep UVA +/- HEV Blue Light Induced Pigmentation and Biomarkers of Cutaneous Oxidative Stress". To assess the level of sub pigmentation following an acute exposure to a Deep Ultraviolet A and high energy Blue Light wavelengths (380-420 nm). This study will compare the unprotected control with test products in Condition #1 and Condition #2 to assess pigmentation as well as cutaneous oxidative s...
What is the current status of trial NCT07695753?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2025-10-27. Estimated completion is 2025-12-06.
What interventions are being tested in trial NCT07695753?
The interventions under investigation include: Sunscreen application #1 (OTHER), Sunscreen application #2 (OTHER).
Who is sponsoring clinical trial NCT07695753?
This trial is sponsored by Kenvue Brands, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.